Nā huahana
-
ʻO ka Antigen Virus SARS-CoV-2 - Hoʻāʻo home
ʻO kēia pahu ʻike no ka ʻike ʻana i ka antigen SARS-CoV-2 in vitro i loko o nā laʻana swab ihu. Ua manaʻo ʻia kēia hoʻāʻo no ka hoʻohana ponoʻī ʻana ma ka home me ke kauka ʻole me nā laʻana swab nasal mua (nares) i hōʻiliʻili ponoʻī ʻia mai nā poʻe he 15 mau makahiki a ʻoi paha i manaʻo ʻia he COVID-19 a i ʻole nā laʻana swab nasal i hōʻiliʻili ʻia e nā pākeke mai nā poʻe ma lalo o 15 mau makahiki i manaʻo ʻia he COVID-19.
-
ʻO ka maʻi kuni melemele ka waikawa nukleika
He kūpono kēia pahu hana no ka ʻike ʻana i ka waikawa nucleic o ka maʻi Yellow Fever i loko o nā laʻana serum o nā maʻi, a hāʻawi i kahi ala kōkua kūpono no ka ʻike lapaʻau a me ka mālama ʻana i ka maʻi Yellow Fever. No ka ʻike lapaʻau wale nō nā hopena hoʻāʻo, a pono e noʻonoʻo pono ʻia ka ʻike hope loa me ka hui pū ʻana me nā ʻōkuhi lapaʻau ʻē aʻe.
-
Ka helu HIV
Hoʻohana ʻia ka HIV Quantitative Detection Kit (Fluorescence PCR) (i kapa ʻia ma hope aku ʻo ke kit) no ka ʻike ʻana i ka nui o ka human immunodeficiency virus (HIV) RNA i loko o nā laʻana serum kanaka a i ʻole plasma.
-
ʻAkika Nukleika Plasmodium
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka qualitative in vitro o ka malaria parasite nucleic acid i loko o nā hāpana koko peripheral o nā maʻi i manaʻo ʻia he maʻi plasmodium.
-
ʻO ka waikawa nukleika Candida Albicans
Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana in vitro o ka waikawa nucleic Candida Albicans i loko o nā hāpana hoʻokuʻu vaginal a me nā hāpana sputum.
-
Pahu ʻIke Waikawa Nucleic e pili ana i ka Enzymatic Probe Isothermal Amplification (EPIA) no Candida Albicans
Ua manaʻo ʻia kēia pahu hana no ka ʻike qualitative in vitro o ka waikawa nucleic o Candida tropicalis i nā laʻana o ke ala genitourinary a i ʻole nā laʻana sputum lapaʻau.
-
ʻO ka mea hoʻohuihui maʻi influenza A/B
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative o nā antigens influenza A a me B i loko o nā laʻana swab oropharyngeal a me nā laʻana swab nasopharyngeal.
-
ʻO ka maʻi hanu o ka Hikina Waena Coronavirus Nucleic Acid
Hoʻohana ʻia ka pahu hana no ka ʻike qualitative o ka MERS coronavirus nucleic acid i loko o nā swabs nasopharyngeal me ka Middle East Respiratory Syndrome (MERS) coronavirus.
-
ʻO ka waikawa nukleika Mycoplasma Pneumoniae
Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana i ka waikawa nucleic Mycoplasma pneumoniae (MP) in vitro i loko o nā ʻāpana puʻu kanaka.
-
14 ʻAno o ka HPV Nucleic Acid Typing
No ka ʻohana Papillomaviridae ka Human Papillomavirus (HPV) o kahi maʻi DNA poepoe pālua liʻiliʻi, ʻaʻole i hoʻopuni ʻia, me ka lōʻihi o ka genome ma kahi o 8000 mau hui kumu (bp). Hoʻopilikia ka HPV i nā kānaka ma o ka pili pololei a ʻaʻole paha me nā mea i haumia a i ʻole ka lawe ʻana i ka moekolohe. ʻAʻole wale ka maʻi i kikoʻī i ka mea hoʻokipa, akā i kikoʻī pū kekahi, a hiki ke hoʻopilikia wale i ka ʻili kanaka a me nā pūnaewele epithelial mucosal, e hana ana i nā ʻano papillomas a i ʻole nā warts i loko o ka ʻili kanaka a me ka hōʻino nui ʻana i ka epithelium o ke ala hānau.
He kūpono kēia pahu hana no ka ʻike ʻana i ke ʻano qualitative in vitro o nā ʻano 14 o nā human papillomaviruses (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) nucleic acids i loko o nā laʻana mimi kanaka, nā laʻana swab cervical wahine, a me nā laʻana swab vaginal wahine. Hiki iā ia ke hāʻawi wale i nā mea kōkua no ka ʻike ʻana a me ka mālama ʻana i ka maʻi HPV.
-
ʻO ka waikawa nukleika o ka maʻi influenza B
Ua manaʻo ʻia kēia pahu hana no ka ʻike qualitative in vitro o ka nucleic acid o ka maʻi Influenza B i nā laʻana swab nasopharyngeal a me oropharyngeal.
-
ʻO ka waikawa nukleika o ka maʻi influenza A
Hoʻohana ʻia ka pahu hana no ka ʻike qualitative o ka nucleic acid o ka maʻi Influenza A i loko o nā swabs pharyngeal kanaka in vitro.
